Scientific Industries Inc (OTCPK:SCND)

$ 1.04 0 (0%) Market Cap: 10.92 Mil Enterprise Value: 8.98 Mil PE Ratio: 0 PB Ratio: 1.00 GF Score: 47/100

Q3 2024 Scientific Industries Inc Earnings Call Transcript
Nov 15, 2024

$0.75 (+0.01%)

Earnings
Q2 2024 Scientific Industries Inc Earnings Call Transcript
Aug 15, 2024

$1.5

Earnings
Q1 2024 Scientific Industries Inc Earnings Call Transcript
May 16, 2024

$1.89 (-5.50%)

Earnings
Q4 2023 Scientific Industries Inc Earnings Call Transcript
Apr 03, 2024

$1.99

Earnings
Q2 2023 Scientific Industries Inc Earnings Call Transcript
Aug 15, 2023

$4.75

Earnings
Q1 2023 Scientific Industries Inc Earnings Call Transcript
May 16, 2023

$4.6

Earnings
Q2 2023 Scientific Industries Inc Earnings Call Transcript
Apr 18, 2023

$4.5 (-2.17%)

Earnings
Q1 2023 Scientific Industries Inc Earnings Call Transcript
Nov 15, 2022

$5.54

Earnings
Scientific Industries Inc at Lytham Partners Fall Investor Conference (Virtual) Transcript
Sep 28, 2022
Scientific Industries Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
Apr 04, 2022
Q2 2022 Scientific Industries Inc Earnings Call Transcript
Feb 22, 2022

$6.1 (+2.52%)

Earnings
Scientific Industries Inc at Lytham Partners Fall Investor Conference (Virtual) Transcript
Oct 05, 2021

Q1 2023 Scientific Industries Inc Earnings Call Transcript

Nov 15, 2022 / 09:30PM GMT

Release Date Price: $5.54

Transcript 10-Q

Operator

Good day, and welcome to the Scientific Industries Reports First Quarter of Fiscal 2023 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Mr. Joe Dorame. Please go ahead, sir.

Joe L. Dorame

Lytham Partners, LLC - Managing Partner

Thanks, Chuck. Good afternoon, and thank you for joining us today to review the financial results of Scientific Industries, Inc. for the first quarter of fiscal year 2023 ended September 30, 2022. With us today on the call are Helena Santos, Chief Executive Officer; Daniel Greunes, CEO of Scientific Bioprocessing; and John Moore, Chairman.

After the conclusion of today's prepared remarks, we will open the call for questions. Before we begin with prepared remarks, I would like to remind everyone, certain statements made by the management team of Scientific Industries during this conference call constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.